居里 CRIS 深 沪
等待开盘 12-16 09:30:00 美东时间
1.19
+0.030
+2.59%
华盛通- 最 高1.24
- 今 开1.18
- 成交量 29.86万股
- 最 低 1.135
- 昨 收 1.16
- 总市值 1538.54万
- 52周最高 4.50
- 市盈率 静 --
- 换手率 2.31%
- 52周最低 1.02
- 委 比 -14.16%
- 总股本 1292.89万
- 历史最高 565.00
- 量 比 3.03
- 振 幅 9.05%
- 历史最低 1.02
- 每 手 1
- 风险率 0.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Curis Provides Updated Data from its Frontline AML Triplet Study
5 of 8 patients (62.5%) achieved Undetectable MRD (uMRD) LEXINGTON, Mass., Dec. 9, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emav...
12-09 21:00
Curis shares are trading lower. The company reported Q3 financial results.
Curis shares are trading lower. The company reported Q3 financial results.
11-08 00:49
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
易方达标普生物科技LOF三季报解读：C类份额激增309.9% 净值增长率18.38%
主要财务指标：AC类利润双增长 期末净值A类1.4368元 报告期内，易方达标普生物科技指数（QDII-LOF）A类和C类份额均实现盈利，期末净值保持稳定。...
10-27 22:43
On October 20, 2025, Curis Received Nasdaq Notice Indicating That The Panel Has Granted The Company An Exception Until November 14, 2025T o Regain Compliance With The MVLS Requirement
As previously disclosed, on August 21, 2025, Curis, Inc. (the "Company") received notice from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") stating that, because the
10-25 04:07
好买股权母基金捷报：9月，26家被投企业获后轮融资
（来源：好买臻财VIP） 欢迎来到好买臻财VIP每月固定栏目 好买股权母基金捷报 2025年前三季度中国股权投资市场投资聚...
10-21 17:34
小核酸公司靖因药业港交所递表：上半年扭亏，暂无商业化产品收入
又有小核酸疗法公司计划港股上市。 9月28日，靖因药业向港交所递交上市申请，高盛、海通国际、汇丰为联席保荐人。靖因药业由OrbiMed Entities及 C...
09-29 18:35
Aptevo Expands Anti-Cancer Pipeline With Patents For APVO452, APVO451; Acute Myeloid Leukemia Candidate Mipletamig Shows Strong Clinical Validation
New candidates, APVO452 and APVO451, harness proprietary ADAPTIR-FLEXTM design to target prostate and multiple solid tumor cancers by simultaneously engaging tumor antigens, T cells, and immunosuppressive
09-04 20:50
